Skip to main content
. 2024 Jan 17;271(3):1063–1071. doi: 10.1007/s00415-024-12186-7

Fig. 5.

Fig. 5

Forest plots of risk ratio between observed and expected GBS linked to COVID-19 vaccine doses administered regardless the vaccine technology; B with respect to vector-based vaccines; C with respect to mRNA vaccines. For vaccinated, Events: number of GBS cases; Total: number of vaccine doses. For expected, Events: number of expected GBS cases; Total: number of subjects in the population considered. AdV: adenoviral-vectored vaccines